Cargando...
Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing
Despite early successes using recombinant adeno-associated virus (rAAV) vectors in clinical gene therapy trials, limitations remain making additional advancements a necessity. Some of the challenges include variable levels of pre-existing neutralizing antibodies and poor transduction in specific tar...
Guardado en:
| Publicado en: | Hum Gene Ther |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232707/ https://ncbi.nlm.nih.gov/pubmed/32024384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2019.339 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|